TrianglePUBLICATIONS · 19047282
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Jan 20
- First author
- Bagatell R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bagatell R
- type
- Author
- name
- Beck-Popovic M
- type
- Author
- name
- London WB
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Pearson AD
- type
- Author
- name
- Matthay KK
- type
- Author
- name
- Monclair T
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Cohn SL
- type
- Author
- name
- International Neuroblastoma Risk Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Bagatell R
- type
- Author
- name
- Beck-Popovic M
- type
- Author
- name
- London WB
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Pearson AD
- type
- Author
- name
- Matthay KK
- type
- Author
- name
- Monclair T
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Cohn SL
- type
- Author
- name
- International Neuroblastoma Risk Group
- type
- CollectiveName
- bibliography ids
- nci-bib-6effc80f9cb8ac026c5d5637
- book metadata
- content sha256
- 31d6114075729136d4be1313ad61971615e713b4b4fa5b311e6297d2e1c7395a
- document type
- citation
- dois
- 10.1200/JCO.2008.17.9184
- electronic publication date
- display
- 2008 Dec 1
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19047282
- immutable id
- pubmed:19047282@31d6114075729136d4be1313ad61971615e713b4b4fa5b311e6297d2e1c7395a
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 365-70
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19047282
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 247ac3d3c222ea16fe3ffbd3d646e20f327597d7240345f6638d4f2635921ddd
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Jan 20
- precision
- day
- year
- 2009
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Preserved source evidence · Independent clinical review pending · Not medical advice